1439-7595 < 1439-7609 < 1439-7803

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f KwdFr.f Mesh.f MeshFr.f Teeft.f

List of bibliographic references indexed by 1439-7609

Number of relevant bibliographic references: 144.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000021 (2020)	Jumpei Temmoku [Japon] ; Yuya Fujita [Japon] ; Naoki Matsuoka [Japon] ; Takeshi Urano [Japon] ; Makiko Yashiro Furuya [Japon] ; Tomoyuki Asano [Japon] ; Shuzo Sato [Japon] ; Haruki Matsumoto [Japon] ; Hiroshi Watanabe [Japon] ; Hideko Kozuru [Japon] ; Hiroshi Yatsuhashi [Japon] ; Atsushi Kawakami [Japon] ; Kiyoshi Migita [Japon]	Uric acid-mediated inflammasome activation in IL-6 primed innate immune cells is regulated by baricitinib.
000052 (2020)	Yasuhiko Hirabayashi [Japon]	Tocilizumab, an anti-interleukin-6 receptor antibody, efficiently ameliorates persistent joint inflammation in rheumatoid arthritis.
000098 (2020)	Seda Colak [Turquie] ; Emre Tekgoz [Turquie] ; Muhammet Cinar [Turquie] ; Sedat Yilmaz [Turquie]	The assessment of tocilizumab therapy on recurrent attacks of patients with familial Mediterranean fever: A retrospective study of 15 patients.
000156 (2020)	Shuichiro Nakabo [Japon] ; Yuko Tsuji [Japon] ; Maiko Inagaki [Japon] ; Hideaki Tsuji [Japon] ; Toshiki Nakajima [Japon] ; Kosaku Murakami [Japon] ; Chikashi Terao [Japon] ; Motomu Hashimoto [Japon] ; Moritoshi Furu [Japon] ; Masao Tanaka [Japon] ; Hiromu Ito [Japon] ; Takao Fujii [Japon] ; Tsuneyo Mimori [Japon] ; Yasutomo Fujii [Japon]	Severe joint deformity and Patient Global Assessment of Disease are associated with discrepancies between sonographic and clinical remission: A cross-sectional study of rheumatoid arthritis patients.
000191 (2020)	Yoshiya Tanaka [Japon] ; Hideto Kameda [Japon] ; Kazuyoshi Saito [Japon] ; Yuko Kaneko [Japon] ; Eiichi Tanaka [Japon] ; Shinsuke Yasuda [Japon] ; Naoto Tamura [Japon] ; Keishi Fujio [Japon] ; Takao Fujii [Japon] ; Toshihisa Kojima [Japon] ; Tatsuhiko Anzai [Japon] ; Chikuma Hamada [Japon] ; Yoshihisa Fujino [Japon] ; Shinya Matsuda [Japon] ; Hitoshi Kohsaka [Japon]	Response to tocilizumab and work productivity in patients with rheumatoid arthritis: 2-year follow-up of FIRST ACT-SC study.
000405 (2020)	Kyosuke Hattori [Japon] ; Yuji Hirano [Japon] ; Yasuhide Kanayama [Japon] ; Yosuke Hattori [Japon] ; Takefumi Kato [Japon] ; Nobunori Takahashi [Japon] ; Naoki Ishiguro [Japon] ; Toshihisa Kojima [Japon]	Efficacy of add-on iguratimod in patients with rheumatoid arthritis who inadequately respond to either tocilizumab or tumor necrosis factor alpha inhibitors.
000407 (2020)	Ambrish Singh [Australie] ; Debashish Danda [Inde] ; Salman Hussain [Inde] ; Abul Kalam Najmi [Inde] ; Ashish Mathew [Inde] ; Ruchika Goel [Inde] ; Shaheen E. Lakhan [États-Unis] ; Belzik Tajudheen [Inde] ; Benny Antony [Australie]	Efficacy and safety of tocilizumab in treatment of Takayasu arteritis: A systematic review of randomized controlled trials.
000491 (2020)	Miho Murakami [Japon] ; Takeshi Johkoh [Japon] ; Seiji Hayashi [Japon] ; Shiro Ohshima [Japon] ; Masao Mizuki [Japon] ; Shin-Ichi Nakatsuka [Japon] ; Minako Tomobe ; Kazuyuki Kuroyanagi ; Ayako Nakasone ; Norihiro Nishimoto [Japon]	Clinicopathologic characteristics of 342 patients with multicentric Castleman disease in Japan.
000502 (2020)	Kazuhisa Nakano [Japon] ; Kazuyoshi Saito [Japon] ; Aya Nawata [Japon] ; Kentaro Hanami [Japon] ; Satoshi Kubo [Japon] ; Ippei Miyagawa [Japon] ; Yoshihisa Fujino [Japon] ; Shingo Nakayamada [Japon] ; Yoshiya Tanaka [Japon]	Clinical aspects in patients with rheumatoid arthritis complicated with lymphoproliferative disorders without regression after methotrexate withdrawal and treatment for arthritis after regression of lymphoproliferative disorders.
000581 (2020)	Atsushi Noguchi [Japon] ; Shinsuke Yasuda [Japon] ; Ryo Hisada [Japon] ; Masaru Kato [Japon] ; Kenji Oku [Japon] ; Toshiyuki Bohgaki [Japon] ; Miho Suzuki [Japon] ; Yoshihiro Matsumoto [Japon] ; Tatsuya Atsumi [Japon]	Anti-cyclic citrullinated peptide antibody titers decrease in rheumatoid arthritis patients treated with tocilizumab: A pilot study.
000767 (2019)	Yoshihito Shima [Japon]	The benefits and prospects of interleukin-6 inhibitor on systemic sclerosis.
000768 (2019)	Kosuke Ebina [Japon] ; Akira Miyama [Japon] ; Hideki Tsuboi [Japon] ; Shoichi Kaneshiro [Japon] ; Masataka Nishikawa [Japon] ; Hajime Owaki [Japon] ; Shigeyoshi Tsuji [Japon] ; Makoto Hirao [Japon] ; Yuki Etani [Japon] ; Atsushi Goshima [Japon] ; Jun Hashimoto [Japon] ; Hideki Yoshikawa [Japon]	The add-on effectiveness and safety of iguratimod in patients with rheumatoid arthritis who showed an inadequate response to tocilizumab.
000822 (2019)	Yasuharu Nakashima [Japon] ; Masakazu Kondo [Japon] ; Eisuke Shono [Japon] ; Takashi Ishinishi [Japon] ; Hiroshi Tsukamoto [Japon] ; Koji Kuroda [Japon] ; Akira Maeyama [Japon] ; Hiroshi Harada [Japon] ; Masayuki Maekawa [Japon] ; Takashi Shimauchi [Japon] ; Ryuji Nagamine [Japon] ; Hiroshi Jojima [Japon] ; Seiji Yoshizawa [Japon] ; Tomomi Tsuru [Japon] ; Takeshi Otsuka [Japon] ; Hisaaki Miyahara [Japon] ; Eiichi Suematsu [Japon] ; Ken Wada [Japon] ; Shigeru Yoshizawa [Japon] ; Yasushi Inoue [Japon] ; Takaaki Fukuda [Japon] ; Satoshi Ikemura [Japon] ; Akihisa Haraguchi [Japon]	Suppression of joint destruction with subcutaneous tocilizumab for Japanese patients with rheumatoid arthritis in clinical practice.
000889 (2019)	Ryuhei Yasuoka [Japon] ; Naomi Iwata [Japon] ; Naoki Abe [Japon] ; Toaki Kohagura [Japon] ; Haruna Nakaseko [Japon] ; Masaki Shimizu [Japon] ; Shinji Kawabe [Japon]	Risk factors for hypersensitivity reactions to tocilizumab introduction in systemic juvenile idiopathic arthritis.
000955 (2019)	Tomo Nozawa [Japon] ; Kenichi Nishimura [Japon] ; Asami Ohara [Japon] ; Ryoki Hara [Japon] ; Shuichi Ito [Japon]	Primary varicella infection in children with systemic juvenile idiopathic arthritis under tocilizumab therapy.
000965 (2019)	Masaru Kato [Japon] ; Yuko Kaneko [Japon] ; Yoshiya Tanaka [Japon] ; Masayuki Inoo [Japon] ; Hitomi Kobayashi-Haraoka [Japon] ; Koichi Amano [Japon] ; Masayuki Miyata [Japon] ; Yohko Murakawa [Japon] ; Hidekata Yasuoka [Japon] ; Shintaro Hirata [Japon] ; Hayato Nagasawa [Japon] ; Eiichi Tanaka [Japon] ; Nobuyuki Miyasaka [Japon] ; Hisashi Yamanaka [Japon] ; Kazuhiko Yamamoto [Japon] ; Isao Yokota [Japon] ; Tatsuya Atsumi [Japon] ; Tsutomu Takeuchi [Japon]	Predictive value of serum amyloid a levels for requirement of concomitant methotrexate in tocilizumab initiation: A post hoc analysis of the SURPRISE study.
000A01 (2019)	Hajime Yoshifuji [Japon]	Pathophysiology of large vessel vasculitis and utility of interleukin-6 inhibition therapy.
000B11 (2019)	Atsushi Ogata [Japon] ; Yoshiya Tanaka [Japon] ; Tomonori Ishii [Japon] ; Motohide Kaneko [Japon] ; Hiroko Miwa [Japon] ; Shino Ohsawa [Japon] ; Reiji Yamakawa [Japon]	Long-term safety and efficacy of weekly subcutaneous tocilizumab monotherapy in patients with rheumatoid arthritis who had an inadequate response to subcutaneous tocilizumab every other week: Results from the open-label extension of the SHINOBI study.
000B57 (2019)	Shinji Akioka [Japon]	Interleukin-6 in juvenile idiopathic arthritis.
000C23 (2019)	Atsushi Ogata [Japon] ; Yasuhiro Kato [Japon] ; Shinji Higa [Japon] ; Kazuyuki Yoshizaki [Japon]	IL-6 inhibitor for the treatment of rheumatoid arthritis: A comprehensive review.
000D56 (2019)	Masakazu Kondo [Japon] ; Hisakata Yamada [Japon]	Drug survival rates of biological disease-modifying antirheumatic drugs and Janus kinase-inhibitor therapy in 801 rheumatoid arthritis patients: a 14 year-retrospective study from a rheumatology clinic in Japan.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/ISSN.i -k "1439-7609" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/ISSN.i  \
                -Sk "1439-7609" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    ISSN.i
   |clé=    1439-7609
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021